{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:57:43Z","timestamp":1774123063042,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.prp.2026.156404","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:18:06Z","timestamp":1771028286000},"page":"156404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bone marrow mesenchymal stromal cells and multiple myeloma: Cellular interactions and therapeutic opportunities"],"prefix":"10.1016","volume":"281","author":[{"given":"Aishwarya","family":"Dash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4406-8299","authenticated-orcid":false,"given":"Man Updesh Singh","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabhajit","family":"Mallik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreejesh","family":"Sreedharanunni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manni","family":"Luthra-Guptasarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 11","key":"10.1016\/j.prp.2026.156404_bib1","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","article-title":"Mesenchymal stem cells reside in virtually all post-natal organs and tissues","volume":"119","author":"da Silva Meirelles","year":"2006","journal-title":"J. Cell Sci."},{"issue":"5411","key":"10.1016\/j.prp.2026.156404_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"5356","key":"10.1016\/j.prp.2026.156404_bib3","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.279.5356.1528","article-title":"Muscle regeneration by bone marrow-derived myogenic progenitors","volume":"279","author":"Ferrari","year":"1998","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.prp.2026.156404_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/hc0302.102593","article-title":"Bone marrow\u2013derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors","volume":"105","author":"Hakuno","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.prp.2026.156404_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI5298","article-title":"Cardiomyocytes can be generated from marrow stromal cells in vitro","volume":"103","author":"Makino","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"5769","key":"10.1016\/j.prp.2026.156404_bib6","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1110542","article-title":"Stem cells and their niches","volume":"311","author":"Moore","year":"2006","journal-title":"Science"},{"issue":"5965","key":"10.1016\/j.prp.2026.156404_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/309255a0","article-title":"Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines","volume":"309","author":"Bradley","year":"1984","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.prp.2026.156404_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000290897","article-title":"Mesenchymal stem or stromal cells: toward a better understanding of their biology?","volume":"37","author":"Lindner","year":"2010","journal-title":"Transfus. Med. Hemotherapy"},{"issue":"5","key":"10.1016\/j.prp.2026.156404_bib9","first-page":"267","article-title":"Fibroblast precursors in normal and irradiated mouse hematopoietic organs","volume":"4","author":"Friedenstein","year":"1976","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.prp.2026.156404_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00003086-198009000-00040","article-title":"Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo","volume":"151","author":"Ashton","year":"1980","journal-title":"Clin. Orthop."},{"issue":"5","key":"10.1016\/j.prp.2026.156404_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1615\/CritRevBiomedEng.v40.i5.10","article-title":"Bone tissue engineering: recent advances and challenges","volume":"40","author":"Amini","year":"2012","journal-title":"Crit. Rev. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.prp.2026.156404_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/scrt537","article-title":"Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells","volume":"6","author":"Laranjeira","year":"2015","journal-title":"Stem Cell Res. Ther."},{"issue":"11","key":"10.1016\/j.prp.2026.156404_bib13","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/81303","article-title":"Stem cell alchemy","volume":"6","author":"Orkin","year":"2000","journal-title":"Nat. Med."},{"issue":"1\u20132","key":"10.1016\/j.prp.2026.156404_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jneuroim.2008.12.005","article-title":"Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1\/Th2\/Th17\/Treg cell subsets through the secretion of TGF-beta","volume":"207","author":"Kong","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.prp.2026.156404_bib15","unstructured":"Lineage of osteogenic cells and their relationship to the stromal system \u2013 ScienceOpen [Internet]. [cited 2023 May 29]. Available from: \u3008https:\/\/www.scienceopen.com\/document?vid=2181b4d2-81a8-4a9d-b5c5-b4c2312b5f6a\u3009."},{"issue":"5","key":"10.1016\/j.prp.2026.156404_bib16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J. Orthop. Res. Off. Publ. Orthop. Res. Soc."},{"issue":"3","key":"10.1016\/j.prp.2026.156404_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0094-1298(20)31020-8","article-title":"The mesengenic process","volume":"21","author":"Caplan","year":"1994","journal-title":"Clin. Plast. Surg."},{"issue":"4","key":"10.1016\/j.prp.2026.156404_bib18","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.3109\/03008209509116826","article-title":"Osteogenesis imperfecta, rehabilitation medicine, fundamental research and mesenchymal stem cells","volume":"31","author":"Caplan","year":"1995","journal-title":"Connect Tissue Res."},{"issue":"4","key":"10.1016\/j.prp.2026.156404_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.prp.2026.156404_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.biocel.2003.10.007","article-title":"Circulating mesenchymal stem cells","volume":"36","author":"Roufosse","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156404_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13287-019-1224-y","article-title":"Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies","volume":"10","author":"Noronha","year":"2019","journal-title":"Stem Cell Res. Ther."},{"issue":"10","key":"10.1016\/j.prp.2026.156404_bib22","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3390\/ijms20102523","article-title":"Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs)","volume":"20","author":"Mazini","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7308","key":"10.1016\/j.prp.2026.156404_bib23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"M\u00e9ndez-Ferrer","year":"2010","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.prp.2026.156404_bib24","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1172\/JCI200420935","article-title":"Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation","volume":"113","author":"Dezawa","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2026.156404_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/2041731420986711","article-title":"Stem cell therapy and tissue engineering strategies using cell aggregates and decellularized scaffolds for the rescue of liver failure","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Tissue Eng."},{"issue":"1","key":"10.1016\/j.prp.2026.156404_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp. Hematol."},{"issue":"5","key":"10.1016\/j.prp.2026.156404_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4252\/wjsc.v6.i5.526","article-title":"Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy","volume":"6","author":"Glenn","year":"2014","journal-title":"World J. Stem Cells"},{"issue":"2","key":"10.1016\/j.prp.2026.156404_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jcp.21200","article-title":"Adult mesenchymal stem cells for tissue engineering versus regenerative medicine","volume":"213","author":"Caplan","year":"2007","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.prp.2026.156404_bib29","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.36922\/bh.2065","article-title":"Therapeutic potential of mesenchymal stem cells and their mechanisms of regeneration for cardiac diseases","volume":"2","author":"Poomani","year":"2024","journal-title":"Brain Heart"},{"issue":"19","key":"10.1016\/j.prp.2026.156404_bib30","first-page":"5002","article-title":"Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium1","volume":"59","author":"Olumi","year":"1999","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156404_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.137.1.231","article-title":"Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies","volume":"137","author":"Weaver","year":"1997","journal-title":"J. Cell Biol."},{"issue":"4\u20135","key":"10.1016\/j.prp.2026.156404_bib32","first-page":"182","article-title":"Anticancer therapeutics: a surge of new developments increasingly target tumor and stroma","volume":"10","author":"Broxterman","year":"2007","journal-title":"Drug Resist Updat Rev. Comment Antimicrob. Anticancer Chemother."},{"issue":"18","key":"10.1016\/j.prp.2026.156404_bib33","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1182\/blood-2008-10-186668","article-title":"CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy","volume":"113","author":"Azab","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.prp.2026.156404_bib34","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","article-title":"Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma","volume":"109","author":"Alsayed","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.prp.2026.156404_bib35","article-title":"Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche? Blood","volume":"2","author":"Noll","year":"2012","journal-title":"Cancer J"},{"issue":"2","key":"10.1016\/j.prp.2026.156404_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers13020217","article-title":"The role of tumor microenvironment in multiple myeloma development and progression","volume":"13","author":"Garc\u00eda-Ortiz","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156404_bib37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1476-4598-9-176","article-title":"Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-\u03baB activity in myeloma cells","volume":"9","author":"Markovina","year":"2010","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.prp.2026.156404_bib38","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.3390\/cancers13112542","article-title":"Bone marrow mesenchymal stromal cells in multiple myeloma: their role as active contributors to myeloma progression","volume":"13","author":"Maiso","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.prp.2026.156404_bib39","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3109\/14653240903253840","article-title":"Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease","volume":"11","author":"Lanzoni","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.prp.2026.156404_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1852517","article-title":"Inflammatory and anti-inflammatory equilibrium, proliferative and antiproliferative balance: the role of cytokines in multiple myeloma","volume":"2017","author":"Musolino","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"10","key":"10.1016\/j.prp.2026.156404_bib41","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1080\/10428190701593644","article-title":"Mesenchymal stem cell abnormalities in patients with multiple myeloma","volume":"48","author":"Garderet","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2026.156404_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.681171","article-title":"Mesenchymal stem cell-macrophage crosstalk and maintenance of inflammatory microenvironment homeostasis","volume":"9","author":"Lu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.prp.2026.156404_bib43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.leu.2404621","article-title":"Bone marrow mesenchymal stem cells are abnormal in multiple myeloma","volume":"21","author":"Corre","year":"2007","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.prp.2026.156404_bib44","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1182\/blood-2003-05-1670","article-title":"Isolation of multipotent mesenchymal stem cells from umbilical cord blood","volume":"103","author":"Lee","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.prp.2026.156404_bib45","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.prp.2026.156404_bib46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/scd.2007.0180","article-title":"Isolation and characterization of adult stem cells from human salivary glands","volume":"17","author":"Rotter","year":"2008","journal-title":"Stem Cells Dev."},{"issue":"24","key":"10.1016\/j.prp.2026.156404_bib47","doi-asserted-by":"crossref","first-page":"15448","DOI":"10.3390\/ijms232415448","article-title":"Molecular features of the mesenchymal and osteoblastic cells in multiple myeloma","volume":"23","author":"Iannozzi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.prp.2026.156404_bib48","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/leu.2009.65","article-title":"Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors","volume":"23","author":"Garayoa","year":"2009","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.prp.2026.156404_bib49","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/1078-0432.CCR-17-2627","article-title":"The pattern of mesenchymal stem cell expression is an independent marker of outcome in multiple myeloma","volume":"24","author":"Schinke","year":"2018","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2026.156404_bib50","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","article-title":"BM mesenchymal stromal cell\u2013derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.prp.2026.156404_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02405-7","article-title":"Proteomic analysis of bone marrow-derived mesenchymal stem cell extracellular vesicles from healthy donors: implications for proliferation, angiogenesis, Wnt signaling, and the basement membrane","volume":"12","author":"McBride","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.prp.2026.156404_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bone.2016.08.006","article-title":"Contact of myeloma cells induces a characteristic transcriptome signature in skeletal precursor cells -Implications for myeloma bone disease","volume":"93","author":"Dotterweich","year":"2016","journal-title":"Bone"},{"issue":"17","key":"10.1016\/j.prp.2026.156404_bib53","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.7150\/jca.25376","article-title":"Mesenchymal stem cell derived exosomes in cancer progression, metastasis and drug delivery: a comprehensive review","volume":"9","author":"Zhou","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2026.156404_bib54","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-021-01141-y","article-title":"Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer","volume":"14","author":"Weng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2026.156404_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103016","article-title":"M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2\/HIF-1\u03b1 axis mediated metabolic reprogramming of macrophages","volume":"69","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.prp.2026.156404_bib56","unstructured":"Dimethyl Fumarate Augments Anticancer Activity of \u00c5ngstrom Silver Particles in Myeloma Cells through NRF2 Activation - Wu - 2025 - Advanced Therapeutics - Wiley Online Library [Internet]. [cited 2026 Feb 10]. Available from: \u3008https:\/\/advanced.onlinelibrary.wiley.com\/doi\/10.1002\/adtp.202400363\u3009."},{"issue":"1","key":"10.1016\/j.prp.2026.156404_bib57","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.celrep.2014.08.042","article-title":"SDF-1 inhibition targets the bone marrow niche for cancer therapy","volume":"9","author":"Roccaro","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.prp.2026.156404_bib58","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3389\/fimmu.2020.01109","article-title":"CAR-T cells hit the tumor microenvironment: strategies to overcome tumor escape","volume":"11","author":"Rodriguez-Garcia","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.prp.2026.156404_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113392","article-title":"Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies","volume":"144","author":"Sun","year":"2025","journal-title":"Int Immunopharmacol"},{"issue":"13","key":"10.1016\/j.prp.2026.156404_bib60","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.2174\/0929867328666210910124319","article-title":"Role of the bone marrow microenvironment in drug resistance of hematological malignances","volume":"29","author":"Hosseini","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.prp.2026.156404_bib61","first-page":"557","article-title":"Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use","volume":"16","author":"Lazarus","year":"1995","journal-title":"Bone Marrow Transpl."},{"issue":"3","key":"10.1016\/j.prp.2026.156404_bib62","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156404_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-021-00725-7","article-title":"Mesenchymal stem\/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications","volume":"28","author":"Zhuang","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.prp.2026.156404_bib64","unstructured":"Study Details | Descartes-25 in Relapsed\/Refractory Multiple Myeloma | ClinicalTrials.gov [Internet]. [cited 2024 Jul 20]. Available from: \u3008https:\/\/clinicaltrials.gov\/study\/NCT05113342\u3009."},{"key":"10.1016\/j.prp.2026.156404_bib65","unstructured":"Study Details | Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies | ClinicalTrials.gov [Internet]. [cited 2024 Aug 28]. Available from: \u3008https:\/\/clinicaltrials.gov\/study\/NCT05672420\u3009."},{"key":"10.1016\/j.prp.2026.156404_bib66","unstructured":"Trial | NCT01045382 [Internet]. [cited 2024 Aug 28]. Available from: \u3008https:\/\/cdek.pharmacy.purdue.edu\/trial\/NCT01045382\/\u3009."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:23:42Z","timestamp":1774121022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":66,"alternative-id":["S0344033826000555"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156404","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow mesenchymal stromal cells and multiple myeloma: Cellular interactions and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156404"}}